Psoriasis is a chronic autoimmune disorder affecting millions worldwide. While conventional treatments exist, their effectiveness is often overshadowed by side effects and costs.

In Patanjali's groundbreaking study, two herbal formulations, Psorogrit and Divya-Taila, showed promise.

Ayurveda views psoriasis as an imbalance in doshas. Patanjali combines detoxification, external therapies, and dietary changes in its treatment plan.

The publication of this research marks a vital step for Ayurveda in the global health landscape. It opens doors for regulatory approvals and positions Patanjali as a leading player in the growing herbal medicine market.

Despite positive findings, experts stress the need for comprehensive human trials. While Ayurveda offers complementary solutions, some dermatologists caution against fully replacing conventional treatments for severe cases of psoriasis.

Patanjali’s plans for further clinical trials could lead to greater insurance coverage and global partnerships. Ongoing research may uncover new pharmacological innovations that enhance the effectiveness of their herbal treatments.

Patanjali’s breakthrough in psoriasis treatment highlights Ayurveda’s relevance in modern medicine. By combining ancient wisdom with contemporary research, there's potential for improved treatments that minimize side effects for countless sufferers.